##  [New Novartis data show Cosentyx demonstrated sustained superiority in skin clearance (PASI 90) versus Stelara at Week 52](/us-en/news/media-releases/new-novartis-data-show-cosentyx-demonstrated-sustained-superiority-skin-clearance-pasi-90-versus-stelara-week-52-0 "New Novartis data show Cosentyx demonstrated sustained superiority in skin clearance (PASI 90) versus Stelara at Week 52") 

  Mar 05, 2016